Fluorescein diacetate vital staining for detecting viability of acid-fast bacilli in patients on antituberculosis treatment | Zendy

Swapna Kanade | Zendy; Gita Nataraj | Zendy; Milind Ubale | Zendy; Preeti Mehta | Zendy

Open Access

Fluorescein diacetate vital staining for detecting viability of acid-fast bacilli in patients on antituberculosis treatment

Author(s) -

Swapna Kanade,

Gita Nataraj,

Milind Ubale,

Preeti Mehta

Publication year - 2016

Publication title -

international journal of mycobacteriology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.53

H-Index - 20

eISSN - 2212-554X

pISSN - 2212-5531

DOI - 10.1016/j.ijmyco.2016.06.003

Subject(s) - rifampicin , staining , isoniazid , sputum , tuberculosis , bacilli , mycobacterium tuberculosis , medicine , acid fast , antibiotics , ziehl–neelsen stain , microbiology and biotechnology , pathology , bacteria , biology , genetics

To determine the performance of FDA vital staining method in detecting viability of acid fast bacilli in comparison with culture and also its correlation with conventional drug susceptibility testing results for isoniazid and rifampicin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research